MAGELLAN HEALTH INC (MGLN)
Common Stock
Taking everything into account, MGLN scores 2 out of 10 in our fundamental rating. MGLN was compared to 118 industry peers in the Health Care Providers & Services industry. While MGLN seems to be doing ok healthwise, there are quite some concerns on its profitability. MGLN is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
MGLN had positive earnings in the past year.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.61% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.03% | ||
| PM (TTM) | 6.26% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
MGLN has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MGLN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.80 indicates that MGLN is not in any danger for bankruptcy at the moment.
MGLN has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.8 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 2.92 indicates that MGLN has no problem at all paying its short term obligations.
A Quick Ratio of 2.86 indicates that MGLN has no problem at all paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.86 |
3. Growth
3.1 Past
MGLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -67.07%.
MGLN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.05% yearly.
The Revenue has been growing slightly by 6.52% in the past year.
The Revenue has been decreasing by -0.09% on average over the past years.
EPS 1Y (TTM)-67.07%
EPS 3Y-32.6%
EPS 5Y6.05%
EPS growth Q2Q-62.5%
Revenue 1Y (TTM)6.52%
Revenue growth 3Y-7.79%
Revenue growth 5Y-0.09%
Revenue growth Q2Q7.18%
3.2 Future
Based on estimates for the next years, MGLN will show a very strong growth in Earnings Per Share. The EPS will grow by 42.68% on average per year.
Based on estimates for the next years, MGLN will show a small growth in Revenue. The Revenue will grow by 7.97% on average per year.
EPS Next Y11.05%
EPS Next 2Y43.46%
EPS Next 3Y36.35%
EPS Next 5Y42.68%
Revenue Next Year8.27%
Revenue Next 2Y8.12%
Revenue Next 3Y8.38%
Revenue Next 5Y7.97%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 87.15 indicates a quite expensive valuation of MGLN.
MGLN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.15.
The Price/Forward Earnings ratio is 27.31, which means the current valuation is very expensive for MGLN.
The average S&P500 Price/Forward Earnings ratio is at 20.20. MGLN is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.15 | ||
| Fwd PE | 27.31 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.26 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as MGLN's earnings are expected to grow with 36.35% in the coming years.
PEG (NY)7.88
PEG (5Y)14.41
EPS Next 2Y43.46%
EPS Next 3Y36.35%
5. Dividend
5.1 Amount
No dividends for MGLN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MAGELLAN HEALTH INC
NASDAQ:MGLN (1/3/2022, 7:23:03 PM)
After market: 94.99 0 (0%)94.99
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.46B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 87.15 | ||
| Fwd PE | 27.31 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)7.88
PEG (5Y)14.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9% | ||
| ROE | 15.61% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.03% | ||
| PM (TTM) | 6.26% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.86 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-67.07%
EPS 3Y-32.6%
EPS 5Y
EPS growth Q2Q
EPS Next Y11.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.52%
Revenue growth 3Y-7.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y